Premium
Labetalol for Prophylactic Treatment of Intractable Migraine During Pregnancy
Author(s) -
Dey Ranjan,
Khan Sajid,
Akhouri Vimal,
Wootton Joshua,
Bajwa Zahid H.
Publication year - 2002
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1046/j.1526-4610.2002.02152.x
Subject(s) - labetalol , migraine , medicine , headaches , pregnancy , preeclampsia , migraine treatment , pharmacotherapy , acute migraine , anesthesia , zolmitriptan , obstetrics , sumatriptan , surgery , blood pressure , alternative medicine , pathology , biology , genetics , placebo , receptor , agonist
Headaches tend to improve in the majority of migraineurs during pregnancy, but some patients report a worsening of migraine and present a management challenge because of the restrictions of pharmacotherapy during pregnancy. Treatment options become even more limited for pregnant migraineurs who develop preeclampsia. Labetalol was tried successfully in reducing the frequency, duration, and intensity of migraine attacks in a pregnant woman with preeclampsia. There were no significant side effects and the patient delivered a healthy baby without complications.